Urticaria is an inflammatory skin disorder that affects up to 20% of the world population at
some point during their life. It presents with wheals, angioedema or both due to activation …

This update and revision of the international guideline for urticaria was developed following
the methods recommended by Cochrane and the Grading of Recommendations …

Urticaria is a condition characterized by the development of itchy wheals (hives),
angioedema, or both. The pathophysiology of chronic spontaneous urticaria (CSU) is still …

Chronic spontaneous urticaria (CSU) comes with gut dysbiosis, but its relevance remains
elusive. Here we use metagenomics sequencing and short-chain fatty acids metabolomics …

Chronic spontaneous urticaria (CSU) imposes a significant burden on patients, families and
healthcare systems. Management is difficult, due to disease heterogeneity and insufficient …

Background Omalizumab is the only biological agent approved for patients with chronic
spontaneous urticaria (CSU), but no biomarker is well established for predicting clinical …

Background: Chronic spontaneous urticaria (CSU) is defined as the recurrence of
unprovoked transient wheals and itch for more than 6 weeks. Currently, there is an unmet …

Chronic spontaneous urticaria (CSU) is a debilitating mast cell–driven disease
characterized by recurrent wheals and/or angioedema. Substantial progress has been made …

Chronic urticaria (CU) is a chronic inflammatory skin disease mainly mediated by mast cells.
Lipids exert essential functions in biological processes; however, the role of lipids in CU …

Biomarkers that are able to predict the response to omalizumab (OMA) in chronic
spontaneous urticaria (CSU) are highly valued. The aim of our study was to evaluate the …